Neocortical  ||| S:0 E:12 ||| FW
posttraumatic  ||| S:12 E:26 ||| FW
epileptogenesis  ||| S:26 E:42 ||| FW
Development  ||| S:42 E:54 ||| NNP
of  ||| S:54 E:57 ||| IN
new  ||| S:57 E:61 ||| JJ
excitatory  ||| S:61 E:72 ||| JJ
connectivity  ||| S:72 E:85 ||| NN
and  ||| S:85 E:89 ||| CC
decreases  ||| S:89 E:99 ||| NNS
in  ||| S:99 E:102 ||| IN
Î³-aminobutyric  ||| S:102 E:117 ||| JJ
acid  ||| S:117 E:122 ||| NN
( ||| S:122 E:123 ||| -LRB-
GABA ||| S:123 E:127 ||| NNP
) ||| S:127 E:128 ||| -RRB-
ergic  ||| S:128 E:134 ||| JJ
inhibition  ||| S:134 E:145 ||| NNS
are  ||| S:145 E:149 ||| VBP
mechanisms  ||| S:149 E:160 ||| VBN
underlying  ||| S:160 E:171 ||| VBG
posttraumatic  ||| S:171 E:185 ||| JJ
epileptogenesis  ||| S:185 E:201 ||| NN
in  ||| S:201 E:204 ||| IN
animal  ||| S:204 E:211 ||| JJ
models ||| S:211 E:217 ||| NNS
.  ||| S:217 E:219 ||| .
Experimental  ||| S:219 E:232 ||| JJ
strategies  ||| S:232 E:243 ||| NNS
that  ||| S:243 E:248 ||| WDT
interfere  ||| S:248 E:258 ||| VBP
with  ||| S:258 E:263 ||| IN
these  ||| S:263 E:269 ||| DT
processes ||| S:269 E:278 ||| NNS
,  ||| S:278 E:280 ||| ,
applied  ||| S:280 E:288 ||| VBN
between  ||| S:288 E:296 ||| IN
the  ||| S:296 E:300 ||| DT
trauma  ||| S:300 E:307 ||| NN
and  ||| S:307 E:311 ||| CC
seizure  ||| S:311 E:319 ||| NN
onset ||| S:319 E:324 ||| NN
,  ||| S:324 E:326 ||| ,
are  ||| S:326 E:330 ||| VBP
antiepileptogenic  ||| S:330 E:348 ||| VBN
in  ||| S:348 E:351 ||| IN
the  ||| S:351 E:355 ||| DT
laboratory ||| S:355 E:365 ||| NN
,  ||| S:365 E:367 ||| ,
and  ||| S:367 E:371 ||| CC
have  ||| S:371 E:376 ||| VB
promise  ||| S:376 E:384 ||| NN
for  ||| S:384 E:388 ||| IN
prophylaxis  ||| S:388 E:400 ||| NN
of  ||| S:400 E:403 ||| IN
epileptogenesis  ||| S:403 E:419 ||| NN
after  ||| S:419 E:425 ||| IN
cortical  ||| S:425 E:434 ||| JJ
injury  ||| S:434 E:441 ||| NN
in  ||| S:441 E:444 ||| IN
humans ||| S:444 E:450 ||| NNS
.  ||| S:450 E:452 ||| .
For  ||| S:452 E:456 ||| IN
an  ||| S:456 E:459 ||| DT
expanded  ||| S:459 E:468 ||| JJ
treatment  ||| S:468 E:478 ||| NN
of  ||| S:478 E:481 ||| IN
this  ||| S:481 E:486 ||| DT
topic  ||| S:486 E:492 ||| NN
see  ||| S:492 E:496 ||| VBP
Jasper ||| S:496 E:502 ||| NNP
's  ||| S:502 E:505 ||| POS
Basic  ||| S:505 E:511 ||| NNP
Mechanisms  ||| S:511 E:522 ||| NNPS
of  ||| S:522 E:525 ||| IN
the  ||| S:525 E:529 ||| DT
Epilepsies ||| S:529 E:539 ||| NNP
,  ||| S:539 E:541 ||| ,
Fourth  ||| S:541 E:548 ||| NNP
Edition  ||| S:548 E:556 ||| NNP
( ||| S:556 E:557 ||| -LRB-
Noebels  ||| S:557 E:565 ||| NNP
JL ||| S:565 E:567 ||| NNP
,  ||| S:567 E:569 ||| ,
Avoli  ||| S:569 E:575 ||| NNP
M ||| S:575 E:576 ||| NNP
,  ||| S:576 E:578 ||| ,
Rogawski  ||| S:578 E:587 ||| NNP
MA ||| S:587 E:589 ||| NNP
,  ||| S:589 E:591 ||| ,
Olsen  ||| S:591 E:597 ||| NNP
RW ||| S:597 E:599 ||| NNP
,  ||| S:599 E:601 ||| ,
Delgado-Escueta  ||| S:601 E:617 ||| NNP
AV ||| S:617 E:619 ||| NNP
,  ||| S:619 E:621 ||| ,
eds ||| S:621 E:624 ||| CD
)  ||| S:624 E:626 ||| -RRB-
National  ||| S:626 E:635 ||| NNP
Library  ||| S:635 E:643 ||| NNP
of  ||| S:643 E:646 ||| IN
Medicine  ||| S:646 E:655 ||| NNP
Bookshelf  ||| S:655 E:665 ||| NNP
[ ||| S:665 E:666 ||| -LRB-
NCBI ||| S:666 E:670 ||| NNP
]  ||| S:670 E:672 ||| -RRB-
at  ||| S:672 E:675 ||| IN
http ||| S:675 E:679 ||| NNS
: ||| S:679 E:680 ||| :
-www.ncbi.nlm.nih.gov ||| S:680 E:701 ||| CD
/ ||| S:701 E:702 ||| CD
books ||| S:702 E:707 ||| NNS
) ||| S:707 E:708 ||| -RRB-
.  ||| S:708 E:710 ||| .
